Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vaxiion Therapeutics logo — Harnessing innovative bacterial minicell technology to deliv...

Vaxiion Therapeutics

Harnessing innovative bacterial minicell technology to deliver targeted therapies directly to cancer cells

Founded 2000 Biotechnology, Pharmaceutical

General Information

Company Name Vaxiion Therapeutics
Founded Year 2000
Founders / Decision Makers
Team member
Industries Biotechnology, Pharmaceutical
Social

Get notified when Vaxiion Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaxiion Therapeutics

Vaxiion Therapeutics is a clinical-stage biopharmaceutical company that focuses on advancing a proprietary drug delivery system using its targeted recombinant bacterial minicell (rBMC) technology for cancer treatment. The company's rBMCs are small, chromosomeless bacterial particles designed to be non-living and non-infectious, engineered to encapsulate, target, and deliver a variety of therapeutically relevant molecules directly to cancer cells. Their innovative approach involves harnessing bacterial minicell technology to deliver targeted therapies, including protein toxins, small molecule drugs, RNAi, plasmids, peptides, and imaging agents. Founded in 2000, Vaxiion Therapeutics operates within the biotechnology and pharmaceutical industries. The company's groundbreaking rBMC technology presents an exciting opportunity for disrupting traditional cancer treatment methods by offering a more targeted and potentially effective delivery system for various therapeutic agents. As a potential investment opportunity, Vaxiion Therapeutics showcases a unique approach to cancer treatment, leveraging innovative technology and scientific advancements in drug delivery. The company's focus on targeted therapies and its clinical-stage status position it as a compelling player in the biopharmaceutical landscape, with the potential for significant impact on cancer treatment methodologies. While specific financial details and recent investment data are not provided, the company's innovative approach and focus on a critical healthcare need make it an intriguing prospect for venture capital firms seeking investment opportunities within the biotechnology and pharmaceutical sectors.

Taxonomy: biopharmaceutical, drug delivery system, cancer treatment, rBMC technology, targeted therapy, clinical-stage, bacterial minicell technology, cancer cells, therapeutic molecules, protein toxins, small molecule drugs, RNAi, plasmids, peptides, imaging agents

No funding data available for Vaxiion Therapeutics yet.

Get notified when Vaxiion Therapeutics raises funding

Vaxiion Therapeutics Alternatives & Competitors

Vaxiion Therapeutics vs
Enterome
Enterome France

Delivering the promise of immunotherapy

Series Unknown
49 employees
Biopharma, Biotechnology
Vaxiion Therapeutics vs
ALKemist Bio
ALKemist Bio Italy

Next generation cell therapies for ALK-positive cancer patients

Seed
3 employees
Health and Wellness
Vaxiion Therapeutics vs
Novocure
Novocure Switzerland

Patient-forward: Aspiring to make a difference in cancer

Post Ipo Debt
1384 employees
Biotechnology, Health Care

FAQ About Vaxiion Therapeutics

Harnessing innovative bacterial minicell technology to deliver targeted therapies directly to cancer cells
Vaxiion Therapeutics was founded in 2000.
Vaxiion Therapeutics operates in the following industries: Biotechnology, Pharmaceutical.
Top alternatives and competitors to Vaxiion Therapeutics include Enterome, ALKemist Bio, Novocure, Navaux, Theramir Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaxiion Therapeutics and Enterome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaxiion Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes